caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1972590347

David HakimianMD

PRACTICEILLINOIS CANCER SPECIALISTSSee all providers at this practice →
Hematology-OncologyNiles, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where David Hakimian's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 25 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
NPI 12959108002303,733
ADVOCATE HEALTH AND HOSPITALS CORPORATION1901,283
JANI, SUREKHA70218
John Eklund
Hematology-Oncology · Niles, IL
43560
SIEGFRIED, MICHAEL43189
KHEDKAR, NANDA37134
ENDEAVOR HEALTH CLINICAL OPERATIONS36138
John Phillips
Diagnostic Radiology · Park Ridge, IL
3498
Leonard Klein
Hematology-Oncology · Niles, IL
31648
Glen Geremia
Diagnostic Radiology · Park Ridge, IL
31132
LAURENT, ELISA30141
Bradley Strimling
Diagnostic Radiology · Park Ridge, IL
30133
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
1,260
Unique beneficiaries
—
Total services
16,606
Distinct HCPCS
27
Medicare payment
$841K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 444 Hematology-Oncology providers in IL — top quintile (cohort median 1,266).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
549
Beneficiaries
—
Total drug cost
$4.6M
Distinct drugs
19
Brand share
53.2%
Top prescribed drugs
Zanubrutinib65 claims
Ibrutinib51 claims
Anastrozole50 claims
Lenalidomide48 claims
Hydroxyurea36 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$2K
Payment records
92
By payment type
Food and Beverage$2K
Education$18